Therefore, we suggested that CDCA5 promoted progression of breast cancer via CDCA5/FOXM1/Wnt axis for the first time, CDCA5 may serve as a novel therapeutic target for breast cancer treatment. Here, CDCA5 is linked to breast carcinoma.